ArticlePhysical and engineering sciences in medicine2025
SchizoLMNet: a modified lightweight MobileNetV2- architecture for automated schizophrenia detection using EEG-derived spectrograms.
Article in Physical and engineering sciences in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- DCM-ML: An Electroencephalography-based Classifier for Early Diagnosis of Schizophrenia Based on Dynamic Connectivity Matrices and Machine Learning Algorithms.Basic and clinical neuroscience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Schizophrenia (SZ) is a chronic neuropsychiatric disorder characterized by disturbances in cognitive, perceptual, social, emotional, and behavioral functions. The conventional SZ diagnosis relies on subjective assessments of individuals by psychiatrists, which can result in bias, prolonged procedures, and potentially false diagnoses. This emphasizes the crucial need for early detection and treatment of SZ to provide timely support and minimize long-term impacts. Utilizing the ability of electroencephalogram (EEG) signals to capture brain activity dynamics, this article introduces a novel lightweight modified MobileNetV2- architecture (SchizoLMNet) for efficiently diagnosing SZ using spectrogram images derived from selected EEG channel data. The proposed methodology involves preprocessing of raw EEG data of 81 subjects collected from Kaggle data repository. Short-time Fourier transform (STFT) is applied to transform pre-processed EEG signals into spectrogram images followed by data augmentation. Further, the generated images are subjected to deep learning (DL) models to perform the binary classification task. Utilizing the proposed model, it achieved accuracies of 98.17%, 97.03%, and 95.55% for SZ versus healthy classification in hold-out, subject independent testing, and subject-dependent testing respectively. The SchizoLMNet model demonstrates superior performance compared to various pretrained DL models and state-of-the-art techniques. The proposed framework will be further translated into real-time clinical settings through a mobile edge computing device. This innovative approach will serve as a bridge between medical staff and patients, facilitating intelligent communication and assisting in effective SZ management.
Indexed as
Identifiers
39760847What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.